Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50098311 (CHEMBL3590408) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 794 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Binding affinity to CECR2 (unknown origin) by BROMOscan panel based assay | J Med Chem 58: 6151-78 (2015) Article DOI: 10.1021/acs.jmedchem.5b00773 BindingDB Entry DOI: 10.7270/Q2FN17Z1 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50572130 (CHEMBL4864027) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of human partial length CECR2 (P423 to D543 residues) expressed in bacterial expression system by BROMOscan assay | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00294 BindingDB Entry DOI: 10.7270/Q21V5JRX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514856 (CHEMBL4465880) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50504160 (CHEMBL3133807 | US11773085, Compound B25) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 9.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Oxford Curated by ChEMBL | Assay Description Inhibition of BAZ2A (unknown origin) after 30 mins by AlphaScreen assay | Sci Adv 2: (2016) BindingDB Entry DOI: 10.7270/Q24J0JPZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321463 (6-(but-3-en-1-yl)-4-(3-(difluoromethoxy)-5-(morpho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321476 (6-but-3-enyl-4-[4-fluoro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321462 (6-but-3-enyl-4-[4-fluoro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321465 (6-but-3-enyl-4-[3-methyl-7-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321465 (6-but-3-enyl-4-[3-methyl-7-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321470 (6-but-3-enyl-4-[1-methyl-6-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321468 (6-but-3-enyl-4-[6-(morpholine-4-carbonyl)-1H-benzi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321474 (6-but-3-enyl-4-[4-chloro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321467 (6-but-3-enyl-4-[3-ethyl-7-(morpholine-4-carbonyl)b...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321475 (6-but-3-enyl-4-[3-fluoro-5-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269687 (CHEMBL4073178) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321458 (6-but-3-enyl-4-[3,4-difluoro-5-(morpholine-4-carbo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50157606 (CHEMBL3785432) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Oxford Curated by ChEMBL | Assay Description Alphascreen assay. Binding to CECR2A (domain start/stop: P420-H538) by alphascreen assay | Medchemcomm 7: 2246-2264 (2016) Article DOI: 10.1039/c6md00373g BindingDB Entry DOI: 10.7270/Q2CZ3BRT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321459 (6-but-3-enyl-4-[3-fluoro-5-(3-methylmorpholine-4-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514858 (CHEMBL4577486) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321461 (6-but-3-enyl-4-[3-fluoro-5-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321469 (4-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321464 (6-but-3-enyl-4-[7-(morpholine-4-carbonyl)-3H-benzi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321460 (3-(6-but-3-enyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514899 (CHEMBL4461619) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | Article PubMed | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of CECR2 (unknown origin) by AlphaScreen assay | Citation and Details Article DOI: 10.1016/j.bmcl.2021.128208 BindingDB Entry DOI: 10.7270/Q2M0497K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514896 (CHEMBL4514362) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310905 (2-methyl-7-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50157606 (CHEMBL3785432) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Oxford Curated by ChEMBL | Assay Description Alphascreen assay. Binding to CECR2A (domain start/stop: P420-D543) by alphascreen assay | Medchemcomm 7: 2246-2264 (2016) Article DOI: 10.1039/c6md00373g BindingDB Entry DOI: 10.7270/Q2CZ3BRT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514853 (CHEMBL4557734) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514856 (CHEMBL4465880) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Inhibition of BSP-BODIPY binding to Nanoluc-tagged CECR2 (unknown origin) expressed in HEK293 cells measured after 4 to 6 hrs by NanoBRET assay | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269689 (CHEMBL4075584) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269688 (CHEMBL4077439) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269691 (CHEMBL4076944) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269690 (CHEMBL4104121) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50157606 (CHEMBL3785432) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Curated by ChEMBL | Assay Description Binding affinity to CERC2 (unknown origin) by alphascreen assay | J Med Chem 59: 1271-98 (2016) Article DOI: 10.1021/acs.jmedchem.5b01514 BindingDB Entry DOI: 10.7270/Q2X92D6H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50504160 (CHEMBL3133807 | US11773085, Compound B25) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Oxford Curated by ChEMBL | Assay Description Inhibition of BAZ2A (unknown origin) after 30 mins by AlphaScreen assay | Sci Adv 2: (2016) BindingDB Entry DOI: 10.7270/Q24J0JPZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514858 (CHEMBL4577486) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Inhibition of BSP-BODIPY binding to Nanoluc-tagged CECR2 (unknown origin) expressed in HEK293 cells measured after 4 to 6 hrs by NanoBRET assay | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514877 (CHEMBL4437578) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514878 (CHEMBL4518862) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269694 (CHEMBL4088221) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310911 (6-methyl-4-(2-methyl-3,4-dihydro-1H-isoquinolin-6-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269697 (CHEMBL4062038) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269693 (CHEMBL4062597) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514873 (CHEMBL4436652) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269696 (CHEMBL4081975) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM310910 (4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-N...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514894 (CHEMBL4553980) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50504160 (CHEMBL3133807 | US11773085, Compound B25) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Oxford Curated by ChEMBL | Assay Description Inhibition of BAZ2A (unknown origin) after 30 mins by AlphaScreen assay | Sci Adv 2: (2016) BindingDB Entry DOI: 10.7270/Q24J0JPZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50514892 (CHEMBL4467940) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde Curated by ChEMBL | Assay Description Displacement of Alexa Fluor 647-labeled GSK tracer from FLAG-6His-Tev-fused CECR2 (424 to 543 residue) (unknown origin) measured after 15 mins by TR-... | J Med Chem 63: 5212-5241 (2020) Article DOI: 10.1021/acs.jmedchem.0c00021 BindingDB Entry DOI: 10.7270/Q2RN3C7T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269698 (CHEMBL4093696) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 (Homo sapiens (Human)) | BDBM50269695 (CHEMBL4076384) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Curated by ChEMBL | Assay Description Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay | ACS Med Chem Lett 8: 737-741 (2017) Article DOI: 10.1021/acsmedchemlett.7b00132 BindingDB Entry DOI: 10.7270/Q2862JXN | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 220 total ) | Next | Last >> |